Other studies indicated that the level of O-GlcNAcylation or OGT can be used as a biomarker to predict poor prognosis of LUAD, laryngeal carcinoma, CHOL, ESCC, GC, CRC, RCC, AML, DLBC, and TC (Table 2). Here, OGT is linked to renal cell carcinoma.